Pharmacology and therapeutics of bronchodilators

M Cazzola, CP Page, L Calzetta, MG Matera - Pharmacological Reviews, 2012 - ASPET
Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of
the current management of chronic obstructive pulmonary disease (COPD) and are critical in …

[HTML][HTML] Asthma: from bronchoconstriction to airways inflammation and remodeling

J Bousquet, PK Jeffery, WW Busse… - American journal of …, 2000 - atsjournals.org
Asthma | From Bronchoconstriction to Airways Inflammation and Remodeling | American
Journal of Respiratory and Critical Care Medicine ATS Journals Logo Official Publications …

GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and …

HK Reddel, JM FitzGerald, ED Bateman… - European …, 2019 - Eur Respiratory Soc
GINA no longer recommends treating adults/adolescents with asthma with short-acting
bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a …

[图书][B] Meyler's Side Effects of Drugs 15E: The International Encyclopedia of Adverse Drug Reactions and Interactions

JK Aronson - 2014 - books.google.com
Building on the success of the 14 previous editions, this remarkable reference has been
extensively reorganized and expanded and now comprises almost 1,500 individual drug …

Effect of inhaled formoterol and budesonide on exacerbations of asthma

RA Pauwels, CG Löfdahl, DS Postma… - … England Journal of …, 1997 - Mass Medical Soc
Background The role of long-acting, inhaled β2-agonists in treating asthma is uncertain. In a
double-blind study, we evaluated the effects of adding inhaled formoterol to both lower and …

Asthma outcomes: exacerbations

A Fuhlbrigge, D Peden, AJ Apter, HA Boushey… - Journal of Allergy and …, 2012 - Elsevier
BACKGROUND: The goals of asthma treatment include preventing recurrent exacerbations.
Yet there is no consensus about the terminology for describing or defining “exacerbation” or …

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

PM O'BYRNE, PJ Barnes… - American Journal of …, 2001 - atsjournals.org
The optimal treatment for mild asthma is uncertain. We assessed the effects of adding a long-
acting inhaled beta-agonist, formoterol, to low doses of an inhaled corticosteroid …

Significant variability in response to inhaled corticosteroids for persistent asthma

SJ Szefler, RJ Martin, TS King, HA Boushey… - Journal of Allergy and …, 2002 - Elsevier
Background: A clinical model is needed to compare inhaled corticosteroids (ICSs) with
respect to efficacy. Objective: The purpose of this investigation was to compare the relative …

Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

CM Drysdale, DW McGraw, CB Stack… - Proceedings of the …, 2000 - National Acad Sciences
The human β2-adrenergic receptor gene has multiple single-nucleotide polymorphisms
(SNPs), but the relevance of chromosomally phased SNPs (haplotypes) is not known. The …

Review of psychosocial stress and asthma: an integrated biopsychosocial approach

RJ Wright, M Rodriguez, S Cohen - Thorax, 1998 - thorax.bmj.com
Although consensus has emerged from the clinical, social science, psychological, and
biological literature that psychosocial factors aVect asthma morbidity in children, their role in …